Maverick Capital’s PetMed Express PETS Stock Holding History

Maverick Capital’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,464	Closed	-$282K	–	431
2023 Q3	$282K	Buy	+27,464	New	+$339K	0.01%	233
2023 Q1	–	Sell	-75,161	Closed	-$1.33M	–	527
2022 Q4	$1.33M	Buy	75,161 +18,099	+32%	+$360K	0.03%	118
2022 Q3	$1.11M	Buy	+57,062	New	+$1.21M	0.03%	129
2021 Q1	–	Sell	-76,310	Closed	-$2.45M	–	833
2020 Q4	$2.45M	Buy	+76,310	New	+$2.35M	0.04%	112
2020 Q2	–	Sell	-207,225	Closed	-$5.96M	–	649
2020 Q1	$5.96M	Buy	+207,225	New	+$5.43M	0.13%	70
2018 Q3	–	Sell	-5,525	Closed	-$243K	–	274
2018 Q2	$243K	Buy	+5,525	New	+$214K	﹤0.01%	231
2018 Q1	–	Sell	-95,653	Closed	-$4.35M	–	243
2017 Q4	$4.35M	Buy	+95,653	New	+$3.77M	0.05%	155
2017 Q3	–	Sell	-11,598	Closed	-$471K	–	211
2017 Q2	$471K	Buy	+11,598	New	+$359K	0.01%	173

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital's PETS Position: Q4 2023 in Review

Maverick Capital sold out of PetMed Express (PETS) in Q4 2023, closing a stake of 27,464 shares — an estimated $282K sold.

Maverick Capital first reported a position in PETS in Q2 2017 and held it in 8 quarters. The position peaked at $5.96M in Q1 2020. 130 funds tracked by Wall St. Rank hold PETS as of Q4 2023.

Maverick Capital reported no remaining PetMed Express position as of Q4 2023 after selling out during the quarter.
Maverick Capital sold 27,464 PetMed Express shares in Q4 2023, an estimated $282K.
Maverick Capital first reported a position in PetMed Express in Q2 2017 and held it in 8 quarters.
Maverick Capital's PetMed Express position peaked at $5.96M in Q1 2020.
130 funds tracked by Wall St. Rank held PetMed Express as of Q4 2023.

Based on Maverick Capital's 13F filing for Q4 2023, filed 14 Feb 2024.